iStreet Network Ltd.

₹56.82

+ 2.70 (4.99%)

04:01 pm - close price

BSE: ISTRNETWK

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -1.49Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.49Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -92.48Good: 20

❌

Current Ratio

Bad: 1Current: 3.86Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -92.48Good: 15

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -1.49Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.49Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -92.48Good: 20

❌

Current Ratio

Bad: 1Current: 3.86Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -92.48Good: 15

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Balance Sheet

In Rs. Cr.	201603	202103	202203	202303	202403	202503
Assets+	43812527.00	-	-	-	-	-
Liabilities+	43812527.00	-	-	-	-	-

Cash Flow Statement

In Rs. Cr.	201603	202103	202203	202303	202403	202503
Cash from Operating Activity+	-28344946.00	-	-	-	-	-
Cash from Investing Activity	626900.00	-	-	-	-	-
Cash from Financing Activity	26188084.00	-	-	-	-	-
Net Cash Flow	-1529962.00	-	-	-	-	-
Opening Cash & Cash Equivalents	1983088.00	-	-	-	-	-
Closing Cash & Cash Equivalents	453126.00	-	-	-	-	-

Shareholder Pattern

In %

Cash Flow Statement

In Rs. Cr.	201603	202103	202203	202303	202403	202503
Cash from Operating Activity+	-28344946.00	-	-	-	-	-
Cash from Investing Activity	626900.00	-	-	-	-	-
Cash from Financing Activity	26188084.00	-	-	-	-	-
Net Cash Flow	-1529962.00	-	-	-	-	-
Opening Cash & Cash Equivalents	1983088.00	-	-	-	-	-
Closing Cash & Cash Equivalents	453126.00	-	-	-	-	-

Ratios

Reported EPS

Bad: 2Current: -1.49Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.49Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -92.48Good: 20

❌

Current Ratio

Bad: 1Current: 3.86Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -92.48Good: 15

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -1.49Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.49Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -92.48Good: 20

❌

Current Ratio

Bad: 1Current: 3.86Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -92.48Good: 15

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Balance Sheet

In Rs. Cr.	201603	202103	202203	202303	202403	202503
Assets+	43812527.00	-	-	-	-	-
Liabilities+	43812527.00	-	-	-	-	-

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %

iStreet Network Ltd.

₹56.82

+ 2.70 (4.99%)

04:01 pm - close price

BSE: ISTRNETWK

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

Overview